University Of Arkansas

This early-phase trial is testing whether injecting the MMR vaccine directly into pancreatic tumors is safe and can help shrink them. The study will include 20 adults with borderline resectable or unresectable pancreatic cancer who have already completed standard chemotherapy and…

This phase 2 trial tests whether giving two bispecific antibodies (teclistamab and talquetamab) in sequence, along with other drugs, can improve survival in 50 people with high-risk multiple myeloma. Some participants may also receive a stem cell transplant if cancer cells remain…

This phase 2 trial tests whether a low dose of naltrexone (LDN) can reduce fatigue in men with prostate cancer who are on hormone therapy (ADT). The study will enroll 60 participants and measure fatigue, quality of life, and safety. It is not yet recruiting.

This study tests whether taking essential amino acid supplements before and after spinal surgery helps adults with spinal deformity recover better. Twenty participants will take either the supplement or a placebo for two weeks before surgery and three months after. Researchers wi…

This study tests whether three telehealth visits with a community health worker after childbirth can help new mothers complete their postpartum checkup and spot complications sooner. Researchers will compare 500 women who get these calls plus standard care against those who only …

This study tests whether an online training course for healthcare providers can improve their knowledge, attitudes, and intentions to help patients quit smoking and get screened for lung cancer. About 300 providers who are members of the National Medical Association and serve pat…